All-cause and diabetes-related healthcare costs among US adults with type 2 diabetes initiating exenatide once weekly or insulin glargine.

Eric WittbrodtAmanda M KongLaura Moore-SchiltzPaul Juneau

Published in: Diabetes, obesity & metabolism (2017)

Among adults with T2D, EQW initiators had lower odds of IP admission and lower medical costs in the 12 months after initiation than IG initiators. Higher total costs in EQW patients were driven by greater pharmacy costs.

Keyphrases

healthcare
type diabetes
end stage renal disease
glycemic control
newly diagnosed
ejection fraction
chronic kidney disease
cardiovascular disease
peritoneal dialysis
metabolic syndrome
drug induced
health insurance
patient reported